144 related articles for article (PubMed ID: 5071365)
1. Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients.
Cavagnini F; Peracchi M; Scotti G; Raggi U; Pontiroli AE; Bana R
J Endocrinol; 1972 Sep; 54(3):425-33. PubMed ID: 5071365
[No Abstract] [Full Text] [Related]
2. L-dopa induced growth hormone secretion. Comparison with insulin tolerance test, arginine infusion and sleep induced GH-secretion.
Lucke C; Höffken B; Morgner KD
Acta Endocrinol (Copenh); 1974 Oct; 77(2):241-9. PubMed ID: 4479561
[No Abstract] [Full Text] [Related]
3. [Effect of L-dopa on pituitary TSH and GH secretion in Parkinson's disease].
Sakoda M; Kusaka T; Baba S; Shirakata S
Nihon Naibunpi Gakkai Zasshi; 1972 Jul; 48(4):241-4. PubMed ID: 5066290
[No Abstract] [Full Text] [Related]
4. Stimulation of human-growth-hormone secretion by L-dopa.
Boyd AE; Lebovitz HE; Pfeiffer JB
N Engl J Med; 1970 Dec; 283(26):1425-9. PubMed ID: 5481776
[No Abstract] [Full Text] [Related]
5. Corticosteroid and growth hormone secretion in patients treated with L-dopa.
von Werder K; van Loon GR; Yatsu F; Forsham PH
Klin Wochenschr; 1970 Dec; 48(24):1454-6. PubMed ID: 4324569
[No Abstract] [Full Text] [Related]
6. Plasma growth hormone and insulin response to levodopa and amantadine.
Kytömäki O; Nousiainen R; Pekkarinen A; Rinne UK; Viljanen M
J Neural Transm; 1973; 34(2):145-51. PubMed ID: 4722572
[No Abstract] [Full Text] [Related]
7. L-dopa level in plasma, primary condition for the kinetic effect.
Birkmayer W; Danielcyk W; Neumayer E; Riederer P
J Neural Transm; 1973; 34(2):133-43. PubMed ID: 4722571
[No Abstract] [Full Text] [Related]
8. Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).
Holmsen R; Kvan L; Presthus J; Thoresen GB
Acta Neurol Scand Suppl; 1972; 51():121-2. PubMed ID: 4514336
[No Abstract] [Full Text] [Related]
9. Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy.
Malarkey WB; Cyrus J; Paulson GW
J Clin Endocrinol Metab; 1974 Aug; 39(2):229-35. PubMed ID: 4371345
[No Abstract] [Full Text] [Related]
10. Effects of L-dopa on plasma growth hormones and insulin.
Kytomaki O; Nousiainen R; Pekkarinen A; Rinne U; Siirtola T; Sonninen V; Viljanen M
Acta Neurol Scand Suppl; 1972; 51():125-6. PubMed ID: 4514338
[No Abstract] [Full Text] [Related]
11. Effect of L-dihydroxyphenylalanine upon serum growth hormone concentrations in children and adolescents.
Root AW; Russ RD
J Pediatr; 1972 Oct; 81(4):808-13. PubMed ID: 5074361
[No Abstract] [Full Text] [Related]
12. Dopa-decarboxylase inhibitors.
Lancet; 1973 May; 1(7810):979-80. PubMed ID: 4121597
[No Abstract] [Full Text] [Related]
13. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine.
Kansal PC; Buse J; Talbert OR; Buse MG
J Clin Endocrinol Metab; 1972 Jan; 34(1):99-105. PubMed ID: 5061778
[No Abstract] [Full Text] [Related]
14. Morphological and biochemical studies on liver biopsies of parkinsonian patients treated with levodopa and decarboxylase inhibitor.
Nevalainen T; Riekkinen P; Rinne UK; Sonninen V
Acta Neurol Scand; 1974; 50(1):122-30. PubMed ID: 4365556
[No Abstract] [Full Text] [Related]
15. Effect of L-dopa on plasma free fatty acids and plasma glucose.
Rivera-Calimlim L; Bianchine JR
Metabolism; 1972 Jul; 21(7):611-7. PubMed ID: 5040916
[No Abstract] [Full Text] [Related]
16. Missing indicator function of growth hormone and luteinizing hormone blood levels for dopamine and serotonin concentration in the human brain.
Benkert O; Laakmann G; Souvatzoglou A; von Werder K
J Neural Transm; 1973; 34(4):291-9. PubMed ID: 4544120
[No Abstract] [Full Text] [Related]
17. [The therapeutic effect of L-dopa].
Groneberg P; Struppler A
Naturwissenschaften; 1972 Nov; 59(11):492-6. PubMed ID: 4657650
[No Abstract] [Full Text] [Related]
18. [Serum gonadotropic level under the medication L-dopa].
Janzik HH; Heller S
Arzneimittelforschung; 1974 Aug; 24(8):1084-5. PubMed ID: 4479602
[No Abstract] [Full Text] [Related]
19. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism].
Sato G; Ito H; Handa Y; Takahashi I; Iijima K
No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821
[No Abstract] [Full Text] [Related]
20. Effect of levodopa (L-dopa) on serum growth hormone in children with short stature.
Chakmakjian ZH; Marks JF; Fink CW
Pediatr Res; 1973 Feb; 7(2):71-4. PubMed ID: 4688499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
